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CONCLUSIONS: Results imply that infants with underlying medical disorders that
are not specifically approved for prophylaxis by advisory bodies and current posi-
tion statements are at significant risk for hospitalization with respiratory illness
and RSV infections and may benefit from immunization.
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OBJECTIVES: Compare clinical, economic outcomes among women treated with
hormone therapy (HT) with different treatment patterns. METHODS: We con-
ducted a retrospective database analysis using commercial enrollees from a large
US health plan from 2002 to 2010. HT initiators during the identification period
from 2005 to 2008 were included. The first HT prescription date was the index date.
Women aged 40 and older, having no evidence of pregnancy during the follow-up
period were selected. Continuous enrollment for 3 years pre- and 2 years post-
index was required. Patients were divided into groups based on HT initiation
(Group A: No menopause diagnosis; Group B: within 1 year of diagnosis; Group C:
1-2 years after diagnosis; Group D: 2-3 years after diagnosis). Propensity score
matching (PSM) was used to adjust baseline differences in age, region, medication
type, prescription fills, and pre-index costs and utilizations. Group B was a refer-
ence group (patients with earliest treatment after menopause diagnosis).
RESULTS: Among 14,008 eligible patients, 8,228 were included in group A, 2,418 in
group B, 1,491 in group C, and 1,871 in group D. After comparing A and B using PSM,
2,418 patients from each group were matched. Group A was more likely to have
osteoporosis, post-menopausal osteoporosis, hysterectomy, outpatient visits, and
had a lower medication persistence ratio (MPR) than Group B. A total of 1480 pa-
tients were matched when comparing groups C and B. Group C was more likely to
use bisphosphonates. After comparing groups D and B, 1,713 patients were
matched. Group D used more bisphosphonates and was more likely to have os-
teopenia and higher pharmacy costs. CONCLUSIONS: HT initiators within 1 year
had fewer comorbidities than HT initiators 3 years or more, following menopause
diagnosis. Compared to HT initiators after 1 year, but within 3 years of menopause
diagnosis, HT initiators within 1 year of diagnosis used fewer bisphosphonates.
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OBJECTIVES: In Hungary there are 10 institutes doing in vitro fertilization (IVF). The
aim of the study was perform a data analyzis of the efficiency in an eleven-year
period of Hungary involving all of the institutes’ data. METHODS: The database of
the Hungarian National Health Insurance Fund Administration (NHIFA), the only
health care financing agency in Hungary, was taken for the study. The analysis
covers an 11 years period between 2000 to 2010. IVF success rate was defined as the
proportion of number of live births and the number of IVF treatments. RESULTS: A
total of 71,634 IVF treatments were done between 2000 and 2011 in the 10 institutes.
50 % of the IVF treatments were done from the age of 30 to 36. The total number of
live births was 25,468. The number of single deliveries was 21,400 (84 %), twins 3779
(14.8 %), triplet 284 (1.1 %) and quadruplet 5 (0.02 %). The overall 11 year IVF success
rate was 35.6 %. The success rate showed significant differences among IVF centers
in a range of 31-49 %. The two largest IVF centres had a market share of 60.9 % and
their success rate was 38.4 % and 34.3 % respectively. The highest efficiency was at
the age of 34 (43.1 % birth rate). CONCLUSIONS: The mean of the IVF efficiency was
35.6 % in Hungary in the last 11 years. The best result was in the group of the patient
at the age of 30-36. The efficiency could be increased if the selection of the patients
were defined more precisely.
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OBJECTIVES: Present research aims at impact assessment of a two-year individu-
alized sports-recreational training programme performed regularly in relation to
living profile, self-rated health and salutogenetic sense of coherence (SOC).
METHODS: Enrolling volunteers participating weekly in sports and recreational
trainings for various reasons (health preservation, body toning etc.) were assessed
between 2008 and 2010 (n106, aged 17-61, woman73). Their health and wellness
status was continuously controlled, and duration, type and difficulty of trainings
were determined accordingly. At the beginning and at the end of the programme
status and changes were assessed by Optimal Life Profile (OLP) worked out by
Renger and colleagues, Antonovsky’s SOC-scale, the 4-grade self assessment of
health and Hennenhofer-Heil’s vegetative lability index (VELA). Data were ana-
lyzed by paired Wilcoxon-test and multivariate logistic regression model.
RESULTS: Compared to health and wellness status before the training programme
a significantly positive change could be demonstrated both in dimensions of OLP
and on VELA and SOC-scales. The global indices in all cases were p0.001 according
to the Wilcoxon-test. Age, sex, weekly regularity and duration of trainings were the
independent variables in the multivariate logistic regression model. The probabil-
ity of improving general health status was not influenced by any of the predictors,
however, the chance of improving vegetative lability was significantly greater
among women (p0.012, OR 5,5, CI95% 1,4-8,3), and predominantly increased in
those attending the trainings more times a week or for a longer duration. The
likelihood of enhancing sense of coherence was also present in women (p0.034,
OR3,2 CI95% 1,2 - 6,4). CONCLUSIONS: Individualized and controlled sports and
recreational training has proved to have a positive impact on general health status,
and optimal life profile in people aged 18-61 with no respect to age or sex. It has
enhanced the individual’s sense of coherence that positively affects many aspects
of life.
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OBJECTIVES: Our aim was to prove the effects of pregnancy on gait and maintain-
ing balance. METHODS: Gait and balance testing was performed on 20 young adult
- and 21 healthy pregnant women during 3 trimesters. Bretz stabilometer was used
to determine balance ability and gait parameters. During stabilometer measure-
ments static balance was examined with Romberg test while dynamic balance with
8 programs on a stabilometer. Duration of swing phase, rate of double-limb sup-
port, foot angle and step width were determined during gait study. Allocation of
patients was non randomized. Statistical data were calculated according to mean,
standard deviation, Fisher’s exact test, Student’s t-test methods and the results
were considered to be significant at p0.05. RESULTS: Gait of pregnant women
proved to be slower than that of the control group (p0,046), but the duration of
step-cycle decreased during the course of pregnancy. Duration of swing phase in
the first trimester is shorter compared to the control group (p0,040). The rate of
double-limb support to the total step-cycle showed an increase (p0,023) the third
trimester with the control group was compared. Foot angle of pregnant women in
the first trimester was bigger than that of the control group (p0,029). Pregnant
women’s step width in the first trimester was smaller as compared to the control
group (p0,002). Step width of pregnant women compared in the first and third
trimesters revealed a significant increase (p0,049). The difference in average re-
sults of Romberg with opened and closed eyes tests was not significant. Examina-
tion of dynamic balance showed significant difference between the results of
young adults women and pregnant women (p0,05). Examination data obtained
during the 1st and 3rd trimesters showed a significant improvement (p0,05) in
balance ability as pregnancy progressed. CONCLUSIONS: Our study revealed that
gait kinematics and balance changed during pregnancy.
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OBJECTIVES: The aim was to investigate changes of balance maintenance ability in
different trimesters and during menopause. METHODS: Investigation was per-
formed at the Department of Obstetrics and Gynaecology, Faculty of Medicine,
University of Pécs. Bretz stabilometer was used to determine balance- and coordi-
nation abilities. Static balance was measured with opened- and closed eyes Rom-
berg-test while dynamic balance was examined with the help of I. and II. pro-
grammes of the measuring instrument. The total number of examined subjects’
was 60: 20 young adults, 20 pregnant women (follow-up was performed in the 1st,
2nd and 3rd trimesters) and 20 women in menopause. Those suffering from severe
locomotor disorders, neurological and internal diseases, in the control group with
the existence of gestation and pathological pregnancy were closed out. Statistical
data were calculated according to (mean, standard deviation, range, F-test and
Student’s methods T-probe) MS Excel 2003.RESULTS:Comparison of survey results
of static balance did not show significant difference in the three groups. During the
survey of dynamic balance in the 1st programme significant improvement was
observed analyzing the results of young adults and pregnant women (p0,05).
Comparing the results in case of young adults and in menopause (p0,05) as well as
in groups of pregnant women and in menopause (p0,05) a definite impairment
was observed. In the 2nd programme on the basis of the results in the 4th sub-
programme a significantly worse performance was measured in menopause
(p0,05). CONCLUSIONS: Measurement results proved that in major stages of life,
with ageing, balance ability decreases. In our case, on the basis of survey data in the
1st and 3rd trimesters it is proved that with the progression of trimesters balance
ability significantly improves.
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OBJECTIVES: Assess the impact of the treatment of urinary disorders of the lower
urinary tract (LUT) suggestive of benign prostatic hypertrophy (BPH) using medical
treatment under actual conditions of use. METHODS: A pragmatic cohort patients
treated medically, was followed up for 6 months, using 3 questionnaires: IPSS and
SF12. RESULTS:A total of 182 patients under medical treatment were assessed; 146
patients were treated with phytotherapy, versus 36 patients on “other treatments”.
At inclusion, the patients treated with Serenoa Repens (hexanic extract) versus
other treatments” were different on the following characteristics: age, time since
diagnosis, IPSS score, physical and mental dimension of the SF12. The “change
from baseline” for the scores of the IPSS and SF12 self-assessment questionnaires
between the 2 treatment groups was compared. A linear model was used. We
observed an improvement in the IPSS score from 6 weeks. We were not able to
demonstrate a significant difference between the 2 treatment groups concerning
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the “change from baseline” of the IPSS score (p0.1464). The same applies to the
analyses at 3 and 6 months where the p-values were 0.1156 and 0.1723 respectively.
Concerning the 2 dimensions of SF12 score, we observe an improvement but there
is no statistical difference between the 2 treatment groups (physical dimension,
p0.6954 and 0.9878 at 6 weeks and 6 months respectively; mental dimension,
p0.5139 and 0.9044 at 6 weeks and 6 months respectively). CONCLUSIONS: We
observed an improvement in the IPSS and SF12 scores from 6 weeks. This improve-
ment was not significantly different between the 2 treatment groups. Under actual
conditions of use, the various medical treatments gave similar improvements.
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OBJECTIVES: Impact studies evaluate the benefit of vaccination on specific out-
come measures in real live conditions. Those studies collect raw data that do not
allow for making general assessments because sometimes the numbers are too
low. Modelling techniques can fine-tune the raw data into more harmonised
( parametric) data presentation. But what do we learn after this transformation?
METHODS: We collected data over 5 years on hospitalisation due to rotavirus in-
fection in children  5 years old before (2y) and after (3y) the introduction of
vaccination in 9 Belgian hospitals. We split the annual data by age-group of 2 to 3
months when  1-year-old and by year thereafter over the period of the epidemic
spread. We harmonised the data using Riskview software in Excel
®
. The hypothe-
ses tested are that the age-groups most vulnerable to the disease have the largest
epidemic spread (highest number of weeks/y of cases reported) and that the less
vulnerable age-groups have their spread during the peak weeks of the most vul-
nerable ones. The latter should indicate a way of disease transmission between
age-groups that could be confirmed with vaccination. RESULTS: Pre-vaccination
data analysis indicates the widest spread of the disease in the age-group of 9 to 11
months (39 wks/52) and the smallest ones in the very young (33 wks/52) and the
oldest ones (8 wks/52). The data confirms the spread of the disease in the less
vulnerable ones (younger and older ones) occurring during the peak moment of the
season of the most vulnerable ones. Post-vaccination analysis shows the same
pattern of dependency between the age-groups. CONCLUSIONS: Preferential
spread of the disease starting from the 9 to 11 months old age-group to younger and
older ones can be deduced from the data analysis. This could give an explanation
for the annual self-limiting spread of rotavirus disease.
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OBJECTIVES: Repeat chlamydial infections are known to cause tubal scarring, ec-
topic pregnancy and infertility. CDC has recommended rescreening 3 months after
a diagnosis of Chlamydia. The objective was to examine the rate and predictors of
retesting within 3-6 months among patients (15-50 years) diagnosed with Chla-
mydia in privately insured population. METHODS: A commercial insurance data-
base was used to extract patients with Chlamydia (ICD-9-CM codes: 99.5X, 78.88,
79.88, 79.98, 99.41) in year 2007-2009. The date of first Chlamydia diagnosis was
used as the index date. Patients were required to have private health insurance
6 months before and after the index date. We also defined the re-screening service
for Chlamydia by using the CPT codes: 87270, 87320, 87110, 87491, 87492, and 87801
within 3-6 months after the index date. Logistic regression model was used to
identify factors affecting the likelihood of Chlamydia retesting. RESULTS: Among
2585 persons diagnosed with Chlamydia, the distribution across age group was
59.8% (15-25 years), 31.2% (26-40 years), and 9.0% (41-50). The majority were women
(74.2%). Only 9.8% (252/2585) patients were rescreened within 3-6 months. The rate
of re-screening in 2007, 2008 and 2009 was 9.1%, 10.3%, and 9.2%, respectively. The
rescreened individuals were more likely to be: women but not pregnant (OR2.36,
95% CI: 1.59-3.50), pregnant women (OR3.01, 95% CI: 1.76-5.13), compared to men;
and age 15-25 years old (OR2.65, 95% CI1.33-5.30), compared to the age group
40-50 years. The insurance type, region or index year were not significantly asso-
ciated with retesting. CONCLUSIONS: Low re-screening rates persisted among per-
sons diagnosed with Chlamydia in the private sector. Since insurance type and
region show no impact on retesting, low rates may relate to system-wide problems.
To improve rescreening rate, policy makers should urgently consider policy op-
tions including rescreening of all Chlamydia cases for effective control of the dis-
ease.
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OBJECTIVES: Herpes zoster (HZ), which is caused by reactivation of the varicella-
zoster-virus (VZV), and its main complication postherpetic neuralgia (PHN) are not
notifiable in Germany. HZ disease burden data are needed to i) estimate the eco-
nomic impact of the disease ii) monitor the impact of routine childhood varicella
vaccination on HZ-epidemiology, and iii) guide decision-making related to the de-
velopment of a possible HZ-vaccination recommendation. METHODS: We as-
sessed annual HZ-incidence for 2007/2008 for all ages in person-years (PY). For
HZ-outpatient incidence we utilized the Association of Statutory Health Insurance
Physicians (ASHIP) database containing nationwide routine accounting data. An-
nual number of HZ-associated deaths and HZ-inpatients were identified by using
the Federal Health Monitoring System (FHM). PHN-incidence and loss of quality-
adjusted life years (QALYs) were modelled by multiplying upper and lower limit
estimates for proportion of HZ-cases developing PHN and HZ-related QALY-loss
with number of identified HZ-outpatients. RESULTS: We identified an annual av-
erage of 480,927 HZ-outpatient cases, resulting in a HZ-incidence of 5.9/1,000 PY. Of
these, 63.5% were 50 years and over. On average, 16,964 HZ-associated inpatients
(84% 50 years) and 71 deaths (all 50 years) were reported annually. HZ-outpa-
tient incidence increased by age from 2.71/1,000 PY in people 0-14 years to 13.18/
1,000 PY in people aged 90. In terms of outpatient (6.94 vs. 4.81/1,000 PY) and
inpatient (0.24 vs. 0.17/1,000 PY) HZ-incidence and mortality (0.13 vs. 0.04/100,000
PY) females were significantly more affected. We estimated that PHN-incidence
ranged between 0.18 and 1.33/1,000 PY and that HZ-outpatients lost between 4,807
and 27,179 QALYs annually.CONCLUSIONS:HZ poses a considerable burden on the
health care system in Germany, especially in the elderly. A health economic model
for Germany will be developed, and follow-up assessments of epidemiological and
economic HZ-related disease burden will be performed to monitor the impact of
VZV-vaccinations in Germany.
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ANALYZING THE ADVERSE DRUG REACTIONS OF GERIATRIC POPULATION AT A
REGIONAL ACADEMIC HOSPITAL OF SOUTHERN TAIWAN
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OBJECTIVES: The aging of the Taiwan population is one of the major public health
issues we face now. The physical difference between young and elderly is signifi-
cant and may induce many drug-related problems. Once geriatrics suffered from
adverse drug reactions, they may need for intensive care and increased the finan-
cial burden. Consequently, medication safety is one of the critical issues for elderly.
Analyzing the adverse drug reactions in geriatric patients and announce to health-
care related professionals to prevent the incidences. METHODS: The data was
claimed form Reporting System of Adverse Drug Reaction of a regional teaching
hospital from Jan 2010 to Dec 2010. RESULTS: Four hundred forty cases were ex-
tracted from computer-assisted system. Of 228 geriatrics (51.82%) was enrolled
with mean age 77.03  0.74 years old, including 116 female and 112 male. The
reason to cause adverse drug reaction is Type 1 (58.26 %), undesired pharmacology
reaction, and others were Type 2 (41.74%). The most strategies to management
adverse effects were to cease medicine and give another relievable drug (29.82%),
only cease medicine (28.51%) and varied to alternative medicine (21.93%). Analyz-
ing the severity of event, 55.26% is moderate (needing therapy or inducing to admit
hospital ).CONCLUSIONS:Over half events happened on elderly and make patients
need more advance therapy, and undesired pharmacology effects, which are pre-
ventable, are the most reasons. For this reason, health care related professionals
should pay more attention and monitor closely to enhance medication safety when
a drug was prescribed to elderly.
Individual’s Health – Cost Studies
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OBJECTIVES: To describe the burden of illness associated with neural tube defects
(NTDs) in Germany from a payer perspective. METHODS: Retrospective data of
patients with Spina Bifida (SB) and Encephalocele were analyzed using 2006-2009
German health insurance fund data (Techniker Krankenkasse). Patients were iden-
tified using ICD10 codes, data assessed included outpatient and inpatient care,
rehabilitation, remedies and medical aids, and use of pharmacotherapy. The anal-
ysis was stratified by age group to provide a lifetime burden estimate and was
compared to standardized health care expenditures from the German Risk Com-
pensation Scheme (RSA) to obtain an indicator of incremental burden due to NTD.
RESULTS: Overall, 4,173 patients were identified, 47.2% of whom were male and
95% had SB. 19.6% and 17.5% patients had an additional diagnosis of depression
and incontinence respectively. Costs of patients with SB and Encephalocele were
substantially higher than general population in all age strata. The difference was
highest for patients10 years old (€10,775 vs. €2,360 for1 year olds, €8,398 vs. €833
for 2-5, and €10,686 vs. €863 for 6-10) and smallest for 41-50 (€2,596 vs. €1,101) and
71 group (€5,256 vs. €4,389). Inpatient care contributed 78% of total cost for pa-
tients 0-1, whereas remedies and medical aids accounted for 60% of total cost for
patients 2-5 and 6-10. Among sub-groups, costs of patients with Spina Bifida and
Hydrocephalus were highest, especially in the first 10 years of life. CONCLUSIONS:
The burden of NTD in Germany is substantial and continues throughout the patient
life in terms of the level of health care expenditures and relative to overall popu-
lation. Efforts should be devoted to improving prevention of NTDs and providing
appropriate support for patients, parents, and caregivers, especially in early years.
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ROTAVIRUS GASTROENTERITIS IN VULNERABLE CHILDREN: A UK CASE
CONTROL STUDY
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BACKGROUND: Seasonal epidemics with rotavirus gastroenteritis (RVGE) and re-
spiratory syncytial virus (RSV) represent a significant burden on paediatric clinical
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